Medication Reconciliation And Safety
Help Questions
NCLEX-PN › Medication Reconciliation And Safety
A 57-year-old client with type 2 diabetes is receiving medication administration after a recent prescription change. Allergies: none known. Home meds: insulin glargine 30 units SQ nightly. New inpatient order changed today to insulin glargine 20 units SQ nightly due to hypoglycemia; the MAR still shows 30 units due at 2100. Which action should the nurse take FIRST when reconciling medications?
Document the provider’s earlier verbal change in the nursing notes and give 20 units
Ask the UAP to reprint the MAR and bring it to the bedside
Hold the dose and verify the current insulin order with the prescriber/pharmacy before administration
Administer 30 units as listed on the MAR and recheck glucose at 0200
Explanation
This question tests medication reconciliation and safety in a client with type 2 diabetes after a prescription change. The priority concern is ensuring accurate and safe medication administration to prevent hypoglycemia from outdated dosing. Holding the dose and verifying the current insulin order with the prescriber/pharmacy before administration is the best choice for ensuring client safety as the MAR shows the old 30 units, risking overdose. Administering 30 units ignores the change; documenting verbal without verification is insufficient; and delegating to UAP is inappropriate. The decision-making principle in medication safety is to confirm updates in the MAR before giving. Nurses must hold until clarified. A transferable strategy for medication reconciliation is to cross-verify recent changes against administration records.
A 56-year-old client with rheumatoid arthritis is being discharged. Allergies: none known. Home meds: methotrexate 15 mg PO weekly, folic acid 1 mg daily, and naproxen 500 mg BID. New discharge orders include trimethoprim-sulfamethoxazole DS 1 tab PO BID for 10 days for a skin infection. Which action should the nurse take FIRST when reconciling medications?
Clarify with the prescriber because TMP-SMX can increase methotrexate toxicity risk
Document all discharge medications and provide a printed list to the client
Delegate to the pharmacist to counsel the client about methotrexate weekly dosing
Teach the client to take TMP-SMX with a full glass of water
Explanation
This question tests medication reconciliation and safety in a client with rheumatoid arthritis being discharged. The priority concern is ensuring accurate and safe medication administration to prevent methotrexate toxicity. Clarifying with the prescriber because TMP-SMX can increase methotrexate toxicity risk is the best choice for ensuring client safety as it inhibits folate metabolism, amplifying effects. Teaching to take with water is general; documenting without clarification risks harm; and delegating to pharmacist is secondary. The decision-making principle in medication safety is to flag folate antagonists with methotrexate during discharge. Nurses must seek adjustments. A transferable strategy for medication reconciliation is to screen antibiotics for interactions with immunosuppressants.
A 73-year-old client with chronic constipation and glaucoma reports urinary retention and blurred vision after starting a new medication. Allergies: none known. Current meds: docusate 100 mg PO BID, latanoprost eye drops nightly, and newly started amitriptyline 25 mg PO at bedtime for neuropathic pain. Which medication should the nurse QUESTION based on the client's current list?
Latanoprost eye drops nightly
Encouraging oral fluids as tolerated
Docusate 100 mg PO BID
Amitriptyline 25 mg PO at bedtime
Explanation
This question tests medication reconciliation and safety in a client with constipation and glaucoma reporting new symptoms. The priority concern is ensuring accurate and safe medication administration to avoid anticholinergic effects in glaucoma. Questioning amitriptyline is appropriate because its anticholinergic properties can worsen glaucoma and cause urinary retention. Docusate is for constipation; latanoprost treats glaucoma; and fluids are supportive. The decision-making principle in medication safety is to contraindicate anticholinergics in glaucoma during review. Nurses should correlate symptoms with new meds. A transferable strategy for medication reconciliation is to screen for drug-class contraindications in comorbid conditions.
During shift handover, an LPN is told a 66-year-old client with atrial fibrillation has a new order changing metoprolol tartrate 50 mg PO BID to metoprolol succinate 100 mg PO daily. The MAR still shows both formulations active for today. Allergies: none known. Which action should the nurse take FIRST when reconciling medications?
Document the change in the nursing notes and continue with scheduled doses
Hold the next beta-blocker dose and contact the prescriber/pharmacy to clarify and discontinue the duplicate order
Ask the oncoming nurse to verify the correct formulation at the next shift
Administer metoprolol tartrate now and start succinate tomorrow
Explanation
This question tests medication reconciliation and safety during shift handover for a client with atrial fibrillation. The priority concern is ensuring accurate and safe medication administration to prevent beta-blocker overdose from duplicates. Holding the next dose and contacting the prescriber/pharmacy to clarify and discontinue the duplicate order is the best choice for ensuring client safety as both metoprolol formulations active could cause bradycardia. Administering now risks error; documenting without hold is unsafe; and delegating to next shift delays. The decision-making principle in medication safety is to suspend administration until duplicates are resolved. Nurses must verify order changes in the MAR. A transferable strategy for medication reconciliation is to reconcile during handovers and inactivate outdated orders immediately.
A 46-year-old client with seizure disorder is receiving meds on the unit. Allergies: latex. Current meds include phenytoin 300 mg PO at bedtime and a new order today changed from warfarin to rivaroxaban 20 mg PO daily for DVT. The pharmacy profile still lists warfarin 5 mg daily as active. Which action should the nurse take FIRST when reconciling medications?
Ask the charge nurse to update the medication history when time allows
Document the discrepancy and continue to monitor for bleeding
Administer rivaroxaban now and discontinue warfarin in the MAR
Contact the prescriber/pharmacy to verify anticoagulant therapy and inactivate the duplicate order
Explanation
This question tests medication reconciliation and safety in a client with seizure disorder and a recent anticoagulant change. The priority concern is ensuring accurate and safe medication administration to prevent errors from duplicate orders. Contacting the prescriber/pharmacy to verify anticoagulant therapy and inactivate the duplicate order is the best choice for ensuring client safety as concurrent warfarin and rivaroxaban increase bleeding risk. Administering rivaroxaban and discontinuing warfarin unilaterally is inappropriate; documenting without action risks error; and delegating to the charge nurse delays intervention. The decision-making principle in medication safety is to resolve order duplications promptly during reconciliation. Nurses must verify changes and update records to avoid administration errors. A transferable strategy for medication reconciliation is to flag active overlapping orders in the pharmacy profile and seek immediate clarification.
A 59-year-old client with chronic back pain and depression is admitted for GI bleed. Allergies: none known. Home meds: ibuprofen 600 mg PO TID PRN, sertraline 100 mg PO daily, omeprazole 20 mg PO daily, and aspirin 81 mg PO daily. Admission orders include ketorolac 15 mg IV q6h PRN pain and continue aspirin 81 mg daily. The nurse notes a discrepancy in medication orders. What is the PRIORITY action?
Ask the client’s family to bring in the home medication bottles for verification tomorrow
Administer ketorolac as ordered and reassess pain in 30 minutes
Document that the client uses ibuprofen at home and continue the MAR as written
Hold ketorolac and notify the provider about NSAID use in a client with GI bleed
Explanation
This question tests medication reconciliation and safety in a client admitted for GI bleed with chronic NSAID use. The priority concern is ensuring accurate and safe medication administration to prevent further gastrointestinal injury. Holding ketorolac and notifying the provider about NSAID use in a client with GI bleed is the best choice for ensuring client safety as ketorolac, an NSAID, can exacerbate bleeding. Administering ketorolac ignores the risk; documenting without action fails to intervene; and asking family to bring bottles delays resolution. The decision-making principle in medication safety is to assess for contraindications based on client history during reconciliation. Nurses must withhold potentially harmful drugs and seek clarification immediately. A transferable strategy for medication reconciliation is to correlate home medications with admission diagnoses for potential exacerbations and act preemptively.
A 63-year-old client with bipolar disorder is being discharged after dehydration. Allergies: none known. Home meds: lithium 300 mg PO TID, levothyroxine 75 mcg PO daily, and naproxen 220 mg PO PRN. New discharge orders include starting hydrochlorothiazide 25 mg PO daily for HTN. Which medication should the nurse QUESTION based on the client's current list?
Lithium 300 mg PO TID
Hydrochlorothiazide 25 mg PO daily
Naproxen 220 mg PO PRN pain
Levothyroxine 75 mcg PO daily
Explanation
This question tests medication reconciliation and safety in a client with bipolar disorder discharged after dehydration. The priority concern is ensuring accurate and safe medication administration to prevent lithium toxicity. Questioning hydrochlorothiazide is correct because it can increase lithium levels, especially post-dehydration, risking toxicity. Levothyroxine is unrelated; lithium itself is the home med; and naproxen may interact but is PRN and less immediate. The decision-making principle in medication safety involves monitoring for diuretic-induced drug level changes during discharge. Nurses must evaluate electrolyte balance and drug interactions. A transferable strategy for medication reconciliation is to anticipate how new medications affect steady-state levels of chronic therapies.
A 52-year-old client with major depressive disorder and chronic pain reports restlessness, sweating, and tremor after a recent medication change. Allergies: none known. Current meds: sertraline 100 mg PO daily, tramadol 50 mg PO q6h PRN (started 3 days ago), and acetaminophen 650 mg PRN. Which finding requires IMMEDIATE intervention when reviewing the medication list?
Tramadol use with sertraline in a symptomatic client
Acetaminophen PRN for mild pain
Client reports pain is 4/10 before PRN medication
Sertraline taken once daily in the morning
Explanation
This question tests medication reconciliation and safety in a client with depression and chronic pain reporting new symptoms. The priority concern is ensuring accurate and safe medication administration to avoid serotonin syndrome. Tramadol use with sertraline in a symptomatic client requires immediate intervention because this combination can cause serotonin excess, manifesting as restlessness, sweating, and tremor. Acetaminophen PRN is safe; morning sertraline is standard; and pain level 4/10 is not urgent. The decision-making principle in medication safety is to identify serotonergic interactions during review. Nurses should monitor for syndrome symptoms and intervene. A transferable strategy for medication reconciliation is to screen for additive neurotransmitter effects in polypharmacy.
A 77-year-old client with osteoarthritis is a new admission for acute kidney injury. Allergies: none known. Home meds: lisinopril 20 mg daily, furosemide 40 mg daily, and ibuprofen 600 mg PO TID. Admission orders continue lisinopril and furosemide and add ketorolac IV PRN. Which action should the nurse take FIRST when reconciling medications?
Document the client’s home ibuprofen use and continue the admission orders
Delegate to the UAP to obtain the client’s preferred pain rating scale
Request an order for a stool softener due to opioid-sparing pain plan
Notify the provider about NSAID use and request alternative pain management due to kidney injury
Explanation
This question tests medication reconciliation and safety in a client with osteoarthritis admitted for acute kidney injury. The priority concern is ensuring accurate and safe medication administration to avoid further renal damage from NSAIDs. Notifying the provider about NSAID use and requesting alternative pain management due to kidney injury is the best choice for ensuring client safety as ketorolac and ibuprofen can worsen AKI. Requesting a stool softener addresses constipation but not the core issue; documenting without action risks harm; and delegating to UAP is inappropriate for reconciliation. The decision-making principle in medication safety is to contraindicate nephrotoxic drugs in AKI during admission. Nurses must advocate for safer alternatives. A transferable strategy for medication reconciliation is to align medications with current organ function and adjust accordingly.
A 68-year-old client is a new admission for COPD exacerbation and pneumonia. Allergies: sulfa (hives). Home meds brought from home: albuterol inhaler PRN, tiotropium inhaler daily, prednisone 10 mg PO daily, and theophylline ER 300 mg PO BID. Hospital orders include azithromycin 500 mg PO daily and continue theophylline ER 300 mg PO BID. Which finding requires IMMEDIATE intervention when reviewing the medication list?
Tiotropium is listed as once daily on the home medication list
The client reports using albuterol more than twice daily at home
Prednisone is continued at the client’s home dose
Azithromycin is ordered while the client takes theophylline ER
Explanation
This question tests medication reconciliation and safety in a client admitted for COPD exacerbation and pneumonia. The priority concern is ensuring accurate and safe medication administration to avoid drug interactions that could lead to toxicity. Identifying that azithromycin is ordered while the client takes theophylline ER requires immediate intervention because this combination can increase theophylline levels, risking seizures or arrhythmias. The client using albuterol more than twice daily suggests poor control but is not an immediate interaction; tiotropium once daily is appropriate; and continuing prednisone at home dose is standard without contraindication. The decision-making principle in medication safety is to review for pharmacokinetic interactions during admission reconciliation. Nurses should flag combinations that elevate drug levels and notify providers promptly. A transferable strategy for medication reconciliation is to use drug interaction checkers and prioritize urgent notifications for high-risk pairings.